The European Federation of Pharmaceutical Industries and Associations (EFPIA) Japan said on June 22 that Marc Hasson, chairman and president of Nippon Boehringer Ingelheim, will become vice chair effective July 1. His term will run through March 2027. The appointment…
To read the full story
Related Article
- Novartis’ Pullicino to Helm EFPIA Japan from July
May 22, 2026
- Boehringer Ingelheim Taps Marc Hasson to Lead Japan Operations
October 7, 2025
ORGANIZATION
- Ectopic Fat Research Group Launches to Push Cross-Disciplinary Studies
July 31, 2026
- JPMA Chief Seeks Concrete Reforms to Reward Innovation after Honebuto
July 31, 2026
- Patient Groups Launch Consortium to Improve Access to Drug Information
July 31, 2026
- Radiopharma Group Seeks Faster NHI Coverage for PET Imaging Agents
July 28, 2026
- Generic, Biosimilar Society Adopts 2040 Vision for Japan’s Pharma Industry
July 27, 2026
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…





